Changes in skin scores and abnormal liver function values during ECP
. | Baseline . | . | 3 mo . | . | 6 mo . | . | |||
|---|---|---|---|---|---|---|---|---|---|
. | n, abnormal at baseline . | Median (range) . | n . | % change of median (P) . | n . | % change of median (P) . | |||
| Skin score | 21 | 131 (10-349) | 19 | -46 (.03) | 15 | -53 (.003) | |||
| Alkaline phosphatase | 14 | 384 (141-1009) | 11 | -7 (.37) | 11 | +14 (1.0) | |||
| ALT | 20 | 91 (40-607) | 17 | -29 (.29) | 16 | -47 (.15) | |||
| γGT | 22 | 255 (5-2209) | 18 | +101 (.61) | 17 | +23 (.14) | |||
. | Baseline . | . | 3 mo . | . | 6 mo . | . | |||
|---|---|---|---|---|---|---|---|---|---|
. | n, abnormal at baseline . | Median (range) . | n . | % change of median (P) . | n . | % change of median (P) . | |||
| Skin score | 21 | 131 (10-349) | 19 | -46 (.03) | 15 | -53 (.003) | |||
| Alkaline phosphatase | 14 | 384 (141-1009) | 11 | -7 (.37) | 11 | +14 (1.0) | |||
| ALT | 20 | 91 (40-607) | 17 | -29 (.29) | 16 | -47 (.15) | |||
| γGT | 22 | 255 (5-2209) | 18 | +101 (.61) | 17 | +23 (.14) | |||